Skip to content

A multicenter retrospective cohort study comparing the clinical efficacy of fully robotic surgery with that of fully laparoscopic radical gastrectomy for gastric cancer

A multicenter retrospective cohort study comparing the clinical efficacy of fully robotic surgery with that of fully laparoscopic radical gastrectomy for gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125548
Enrollment
Unknown
Registered
2026-05-28
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Complete robotic radical gastrectomy for gastric cancer group:None
Total laparoscopic radical gastrectomy for gastric cancer group:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age >18 years old, <75 years old; 2.The primary lesion of the stomach was diagnosed as gastric adenocarcinoma (papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell, poorly differentiated adenocarcinoma, etc.) by endoscopic biopsy histopathology. 3.The preoperative clinical stage was early and locally advanced gastric cancer (cT1-4a, N0-3, M0, according to AJCC-8th TNM tumor staging). 4.Preoperative examination showed no distant metastasis, and the tumor did not directly invade the pancreas, spleen or other adjacent organs. 5.The preoperative ECOG physical status score was 0/1. 6.Preoperative ASA score: I - III;

Exclusion criteria

Exclusion criteria: 1.gastric stump carcinoma; 2.The patient underwent emergency surgery due to gastric tumor bleeding, perforation or obstruction; 3.Previous history of upper abdominal surgery (except laparoscopic cholecystectomy); 4.Endoscopic submucosal dissection has been performed, followed by remedial surgery; 5.The patient has a history of other malignant tumors, or other malignant tumors are found to be combined during preoperative examinations;

Design outcomes

Primary

MeasureTime frame
overall survival;

Secondary

MeasureTime frame
Early postoperative complications;

Countries

China

Contacts

Public ContactShi Yan

The First Affiliated Hospital of Army Medical University

shiyandoctor@sina.com+86 13752909448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026